Data from gene expression studies have clustered breast cancers into four main intrinsic subtypes—luminal A, luminal B, HER2-enriched, and basal-like breast cancers (BLBCs)—that display differences in prognosis and response to therapy [3,4,5,6,7,8,9]. Here, ERBB2 is linked to breast carcinoma.